ECHA public consultation on potential candidates for substitution

Last public consultation:

  • Dinotefuran PT 18
  • Medetomidine (RS)-4-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole (Racemic) PT 21
  • N-Didecyl-N-dipolyethoxyammonium borate/Didecylpolyoxethylammonium borate (Polymeric betaine) PT 8

Deadline for communication of information: 04/01/2024

  • 2-methyl-4-oxo-3-(prop-2-ynyl)cyclopent-2-en-1-yl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate (Prallethrin) PT18

Deadline for communication of information: 22/01/2024

More information and commenting on ECHA website:

Last modification 27.11.2023

Top of page